Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Saccharomyces cerevisiae BY4741 cells treated with n-alkanes

ABSTRACT: Transcripitonal profiling of Saccharomyces cerevisiae treated with 2% n-alkanes vs untreatment

ORGANISM(S): Saccharomyces cerevisiae

PROVIDER: GSE38653 | GEO | 2015/04/07

SECONDARY ACCESSION(S): PRJNA168353

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Saccharomyces cerevisiae BY4741 cells treated with n-alkanes

Project description:Transcripitonal profiling of Saccharomyces cerevisiae treated with 2% n-alkanes vs untreatment Multiple condition experiment, S. cerevisiae treated with n-alkanes (n-nonane, n-decane, n-undecane, n-dodecane, respectively) for 24hrs or 48hrs, compared to control (those without treatment)

2015-04-07 | E-GEOD-38653 | biostudies-arrayexpress

Global transcriptional profiling of Saccharomyces cerevisiae treated with allicin

Project description:We employed CapitalBio Corporation to investigate the global transcriptional profiling of Saccharomyces cerevisiae treated with allicin.

2008-06-23 | GSE11856 | GEO

Global transcriptional profiling of Saccharomyces cerevisiae treated with dictamnine

Project description:We employed CapitalBio Corporation to investigate the global transcriptional profiling of Saccharomyces cerevisiae treated with dictamnine. Keywords: response to dictamnine

2007-12-08 | GSE9817 | GEO

Global transcriptional profiling of Saccharomyces cerevisiae treated with thymol

Project description:We employed CapitalBio Corporation to investigate the global transcriptional profiling of Saccharomyces cerevisiae treated with thymol. Keywords: gene expression array-based, count

2008-08-05 | GSE12329 | GEO

Global transcriptional profiling of Saccharomyces cerevisiae treated with p-anisaldehyde

Project description:We employed CapitalBio Corporation to investigate the global transcriptional profiling of Saccharomyces cerevisiae treated with p-anisaldehyde. Keywords: response to p-anisaldehyde

2007-10-24 | GSE9409 | GEO

Effect of the antifungal protein PeAfpA in the expression profile of Saccharomyces cerevisiae BY4741 strain.

Project description:Transcriptomic study to characterize the interaction of the Penicillium expansum antifungal protein PeAfpA with the the model yeast Saccharomyces cerevisiae. For this, the transcriptome of S. cerevisiae BY4741 strain was compared among samples treated with increasing concentrations of PeAfpA.

2023-11-09 | GSE233704 | GEO

CGH of natural Saccharomyces cerevisiae strains

Project description:Comparative Genomic Hybridization of natural Saccharomyces cerevisiae strains vs lab reference strains.

2020-12-31 | GSE136466 | GEO

KP1019 (trans-[tetrachlorobis(1H-indazole) ruthenate(III)]) Dependent Transcription in WT Saccharomyces cerevisiae

2015-10-26 | GSE71805 | GEO

Saccharomyces cerevisiae BY4741

Project description:Saccharomyces cerevisiae BY4741 Epigenomics

| PRJNA178297 | ENA

KP1019 (trans-[tetrachlorobis(1H-indazole) ruthenate(III)]) Dependent Transcription in WT Saccharomyces cerevisiae

Project description:To characterize cellular response to the anti-cancer ruthinium complex KP1019, budding yeast Saccharomyces cerevisiae transcripitonal response to KP1019 was measured using microarray analysis. Although KP1019 molecular mechanism of action remains a matter of debate, the drug has been shown to bind DNA in biophysical assays and to damage DNA of colorectal and ovarian cancer cells in vitro. KP1019 has also been shown to induce mutations and induce cell cycle arrest in Saccharomyces cerevisiae, suggesting that budding yeast can serve as an appropriate model for characterizing the cellular response to the drug. Here we use a transcriptomic approach to characterize KP1019 induced transcriptional changes. Two concentrations of KP1019 (40 micrograms/mL and 80 micrograms/ml were assayed by microarray analysis to obtain comparative expression data for treated and untreated cells of the budding yeast Saccharomyces cerevisiae (strain BY4741). Two biological replicates of each concentration were done. Each biological replicate was done in duplicate to allow for dye reversal controls.

2015-10-26 | E-GEOD-71805 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data